Evidence map›Paper›PMID 35935166›Full record

ArticleAdvanced nanobiomed research2022

(Bio)manufactured Solutions for Treatment of Bone Defects with Emphasis on US-FDA Regulatory Science Perspective.

Pejman Ghelich, Mehdi Kazemzadeh-Narbat, Alireza Hassani Najafabadi, Mohamadmahdi Samandari, Adnan Memic, Ali Tamayol

Abstract read
In one paragraph

Article in Advanced nanobiomed research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Bone Grafts: Everything You Need to Know.Journal of periodontal research · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Natural medicine delivery from 3D printed bone substitutes.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  12. Review
  13. Smart Orthopedic Biomaterials and Implants.Current opinion in biomedical engineering · 2023
    Article
  14. Article
  15. The Use of Collagen-Based Materials in Bone Tissue Engineering.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pejman GhelichDepartment of Biomedical Engineering, University of Connecticut, Farmington, Connecticut, 06030, USA.
Mehdi Kazemzadeh-NarbatMusculoskeletal Clinical Regulatory Advisers (MCRA), Washington DC, US.
Alireza Hassani NajafabadiDepartment of Biomedical Engineering, University of Connecticut, Farmington, Connecticut, 06030, USA.
Mohamadmahdi SamandariDepartment of Biomedical Engineering, University of Connecticut, Farmington, Connecticut, 06030, USA.
Adnan MemicCenter of Nanotechnology, King Abdulaziz University, Jeddah, 21589 Saudi Arabia.
Ali TamayolDepartment of Biomedical Engineering, University of Connecticut, Farmington, Connecticut, 06030, USA.

Funding

Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle lossR01AR077132 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHIN, SU RYON, TAMAYOL, ALI · 2021 to 2025
$2.6M
Microengineered scaffolds carrying patient-specific cells and growth factors for treatment of volumetric muscle lossR01AR073822 · NIAMS · UNIVERSITY OF NEBRASKA LINCOLN · PI TAMAYOL, ALI · 2018 to 2022
$1.8M
NIAMS NIH HHS R01 AR073822NIAMS NIH HHS R01 AR077132
6 · The paper itself

Abstract

Bone defects, with second highest demand for surgeries around the globe, may lead to serious health issues and negatively influence patient lives. The advances in biomedical engineering and sciences have led to the development of several creative solutions for bone defect treatment. This review provides a brief summary of bone graft materials, an organized overview of top-down and bottom-up (bio)manufacturing approaches, plus a critical comparison between advantages and limitations of each method. We specifically discuss additive manufacturing techniques and their operation mechanisms in detail. Next, we review the hybrid methods and promising future directions for bone grafting, while giving a comprehensive US-FDA regulatory science perspective, biocompatibility concepts and assessments, and clinical considerations to translate a technology from a research laboratory to the market. The topics covered in this review could potentially fuel future research efforts in bone tissue engineering, and perhaps could also provide novel insights for other tissue engineering applications.

Indexed as

biomanufacturingbone defectbone graftFDA regulatory science

Identifiers

PMID35935166
PMCPMC9355310

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.